Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Psychiatry indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Wernicke encephalopathy prevention and treatment

Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Treat suspected Wernicke encephalopathy immediately

Confusion, impaired eye movements, ataxia, unexplained hypothermia or hypotension in a malnourished or alcohol-dependent person can represent Wernicke encephalopathy; the full classical triad is often absent and delay risks irreversible brain injury.

Action: Transfer to an acute hospital and give intravenous thiamine 300–500 mg three times daily for 3–5 days with daily review. Correct low magnesium, assess refeeding risk and other causes of confusion, ensure anaphylaxis treatment facilities are available, and continue parenteral then oral treatment according to response.

Overview

Prevent thiamine-deficiency brain injury, recognise the incomplete and easily missed Wernicke presentation, and deliver current UK oral, intramuscular or intravenous thiamine regimens with magnesium, nutrition and refeeding safety.

Thiamine is required for cerebral glucose metabolism. Body stores are limited, and harmful or dependent drinking combines poor intake, impaired absorption, reduced storage and increased metabolic demand. Acute deficiency injures high-demand neural networks and can progress from a reversible encephalopathy to persistent amnesia and executive dysfunction. Although alcohol dependence is the familiar context, prolonged vomiting, starvation, gastrointestinal disease or surgery and other severe malnutrition can produce the same emergency. Prevention depends on identifying nutritional risk before neurological signs appear.

The textbook triad of confusion, gait ataxia and ophthalmoplegia is specific but insensitive. A patient may show only inattentiveness, apathy, memory difficulty, nystagmus, subtle gaze limitation or imbalance. Intoxication, withdrawal, hepatic encephalopathy, head injury and sedation can conceal these signs. Unexplained hypothermia or hypotension can occur. Because no rapid blood test safely rules out the condition and delayed treatment has serious consequences, use a low clinical threshold and begin parenteral thiamine while investigating alternatives.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
PsychiatryOriginal SBA

Suspected Wernicke regimen

A malnourished alcohol-dependent patient develops confusion, horizontal nystagmus and a broad-based gait. Which initial thiamine regimen best matches current UK national guidance?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Psychiatry topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • DHSC alcohol guideline chapter 16 acute hospitalsExplicit high-risk prophylaxis and suspected Wernicke treatment regimens.
  • DHSC alcohol guideline chapter 10 pharmacological interventionsCommunity prophylaxis, risk groups and oral treatment.
  • NICE CG100 alcohol physical complications recommendationsWho should receive oral or parenteral prophylaxis and emergency treatment.
  • NHS SPS using and prescribing thiamine in alcohol dependenceCurrent product availability and replacement of obsolete Pabrinex assumptions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Separate three treatment groups. Harmful or dependent drinkers without high-risk features should receive oral prophylaxis, currently 50 mg four times daily in the national guideline. High-risk features include significant weight loss, poor diet, BMI below 18, malnutrition, memory disturbance, peripheral neuropathy, previous complicated withdrawal, decompensated liver disease, a long history of dependence, or hospital admission with acute illness or injury. These patients need parenteral prophylaxis because alcohol dependence and malnutrition can make oral absorption negligible.

In community care, high-risk prophylaxis is intramuscular thiamine 200–300 mg once daily for at least three days with daily review, then oral thiamine. Transfer to hospital if low muscle mass, a clotting problem or preference makes intramuscular dosing unsuitable. In hospital, give 200–300 mg intramuscularly or intravenously once daily for three to five days and then oral treatment. These are prophylactic doses only: any neurological feature suggesting Wernicke encephalopathy moves the patient immediately to the higher intravenous treatment regimen.

For suspected or established Wernicke encephalopathy, the 2025 UK alcohol guideline specifies intravenous thiamine 300–500 mg three times daily for three to five days, reviewed each day. If symptoms remain after five days, continue 300–500 mg intravenously once daily for a further three to five days and then while clinical improvement continues. Follow with oral thiamine. Check magnesium and replace it when low, because it is necessary for thiamine function. Manage fluids, nutrition and refeeding risk carefully, and investigate other causes rather than interpreting a partial response as proof of a single diagnosis.

Key points

  • Wernicke encephalopathy is a clinical diagnosis caused by inadequate thiamine availability; normal imaging or the absence of the complete triad does not exclude it.
  • Think beyond alcohol withdrawal: risk includes poor diet, low BMI, weight loss, vomiting, decompensated liver disease, memory difficulty, neuropathy and prior complicated withdrawal.
  • Current national lower-risk prophylaxis for harmful or dependent drinkers is oral thiamine 50 mg four times daily, including during medically assisted withdrawal.
  • High-risk community prophylaxis is intramuscular thiamine 200–300 mg once daily for at least 3 days with daily review, then oral thiamine; use an inpatient route if IM is unsuitable.
  • High-risk hospital prophylaxis is intramuscular or intravenous thiamine 200–300 mg once daily for 3–5 days with daily review, followed by oral thiamine.
  • Suspected or established disease requires intravenous thiamine 300–500 mg three times daily for 3–5 days, not oral treatment alone.
  • If still symptomatic after the initial course, give 300–500 mg intravenously once daily for another 3–5 days and thereafter while improvement continues, while looking for another cause.
  • Check and replace magnesium because deficiency can prevent thiamine activation; provide parenteral treatment where anaphylaxis can be recognised and treated.

Aetiology

01

Low thiamine intake

Poor diet, vomiting and displacement of food by alcohol rapidly exhaust small body stores of this essential water-soluble vitamin.

02

Impaired handling

Alcohol dependence can reduce intestinal absorption, hepatic storage and phosphorylation of thiamine, making oral replacement unreliable during malnutrition.

03

Increased metabolic demand

Acute illness, withdrawal and carbohydrate refeeding increase thiamine requirements precisely when tissue stores are least able to meet them.

Pathophysiology

  1. 1
    Energy failure

    Thiamine-dependent enzymes are essential for glucose metabolism, so deficiency impairs ATP production in metabolically active neural tissue.

  2. 2
    Selective neural injury

    Periventricular and diencephalic networks involved in eye movement, balance, attention and memory are particularly vulnerable to metabolic stress.

  3. 3
    Blood-brain delivery

    High parenteral circulating concentrations support passive central nervous system diffusion when active transport and gastrointestinal absorption are inadequate.

  4. 4
    Magnesium dependence

    Magnesium is a cofactor for thiamine activation, so deficiency can create biochemical treatment resistance until both deficits are corrected.

Clinical features and red flags

Mental-state change

Confusion, inattention, apathy, drowsiness, memory difficulty or altered behaviour may be the only obvious neurological manifestation.

Oculomotor abnormality

Nystagmus, impaired abduction, conjugate gaze palsy or ophthalmoplegia provides a strong clue but is frequently absent.

Gait and coordination change

Broad-based gait, inability to stand, truncal instability or limb incoordination may be misattributed to intoxication.

Nutritional vulnerability

Weight loss, low BMI, poor intake, vomiting, neuropathy and decompensated liver disease raise pre-test probability before the triad develops.

Atypical physiology

Unexplained hypothermia, hypotension or reduced consciousness in a high-risk person should lower the threshold for emergency parenteral treatment.

Red flags requiring action

  • Any new confusion, impaired attention or memory disturbance in a malnourished person with harmful or dependent drinking should trigger immediate Wernicke consideration.
  • Ophthalmoplegia, nystagmus, gaze palsy or new unsteady gait is sufficient to escalate even when confusion is subtle or absent.
  • Hypothermia, hypotension, coma or rapidly reduced consciousness may be an atypical severe presentation and requires broad emergency assessment.
  • Persistent symptoms despite thiamine should prompt magnesium re-check and investigation for sepsis, head injury, hepatic encephalopathy, intoxication and other neurological disease.
  • Very low body mass, negligible intake, major weight loss or electrolyte depletion signals simultaneous refeeding-syndrome risk when nutrition restarts.

Investigations

  1. 01
    Immediate clinical assessmentFirst step
    Why
    Identify neurological signs and nutritional risk without delaying treatment for a laboratory result.
    Interpretation and limitations
    One compatible feature in a high-risk context can justify presumptive therapy; absence of the full triad is not reassuring.
  2. 02
    Glucose and electrolyte profile
    Why
    Detect hypoglycaemia, magnesium deficiency, potassium or phosphate depletion and renal impairment.
    Interpretation and limitations
    Correct urgent abnormalities and replace magnesium; phosphate and potassium trends help define refeeding risk.
  3. 03
    Nutrition and refeeding assessment
    Why
    Document weight change, BMI, recent intake, vomiting, alcohol exposure and other malabsorption risks.
    Interpretation and limitations
    Severe depletion requires dietetic planning, slow nutritional escalation and close biochemical monitoring alongside thiamine.
  4. 04
    Cause-directed delirium work-up
    Why
    Look for infection, head injury, hepatic encephalopathy, intoxication, withdrawal, stroke and other causes of altered consciousness.
    Interpretation and limitations
    Wernicke encephalopathy can coexist with another disorder, so improvement or non-improvement does not end diagnostic review.
  5. 05
    Brain imaging when indicated
    Why
    Investigate trauma, focal signs, seizure, atypical course or a competing intracranial diagnosis.
    Interpretation and limitations
    Imaging may support another diagnosis but normal imaging cannot safely exclude Wernicke encephalopathy.

Differential diagnosis

01

Alcohol intoxication or withdrawal

Ataxia, confusion and eye findings may be attributed to alcohol state, while withdrawal autonomic signs can coexist with thiamine deficiency.

02

Hepatic encephalopathy

Liver failure may produce fluctuating consciousness and motor signs and can occur simultaneously in a nutritionally depleted patient.

03

Intracranial or infectious disease

Head injury, stroke, subdural bleeding, meningitis, encephalitis and sepsis require parallel evaluation when the presentation is acute.

04

Other nutritional disorders

Hypoglycaemia, electrolyte depletion, niacin deficiency and refeeding syndrome can overlap and need specific correction rather than thiamine alone.

Management

01PreventionStratify nutritional riskFirst stepA person drinks harmfully or dependently, whether or not withdrawal is planned.+
  1. 1Ask about diet, weight loss, BMI, memory, neuropathy, liver disease, prior complicated withdrawal and acute illness.
  2. 2Give oral thiamine 50 mg four times daily to the lower-risk group; use parenteral prophylaxis for any high-risk pattern.
  3. 3Review intake and recovery, continuing oral thiamine after injections until holistic nutritional and alcohol recovery review supports stopping.
02Emergency treatmentTreat on suspicionA high-risk patient has confusion, eye signs, ataxia, hypothermia, hypotension or otherwise unexplained neurological change.+
  1. 1Transfer to hospital and begin intravenous thiamine 300–500 mg three times daily without waiting for imaging or a thiamine level.
  2. 2Continue for 3–5 days with daily neurological review, anaphylaxis readiness and parallel delirium investigation.
  3. 3If symptoms persist after day 5, continue 300–500 mg intravenously once daily for another 3–5 days and while improvement continues, then oral treatment.
03NutritionPrevent refeeding injuryMarked malnutrition or negligible intake makes electrolyte shift likely when feeding or glucose delivery begins.+
  1. 1Give thiamine before and during nutritional restoration whenever feasible, without delaying treatment of life-threatening hypoglycaemia.
  2. 2Seek dietetic input, introduce energy cautiously according to refeeding risk and avoid using glucose solution as routine rehydration.
  3. 3Monitor phosphate, magnesium, potassium, calcium, fluid balance and cardiac status closely, replacing deficits promptly.
Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
Replaces depleted stores before neurological injury and is required during medically assisted withdrawal as well as for high-risk people who continue drinking.

Thiamine prophylaxis

Lower-risk harmful or dependent drinking: thiamine 50 mg orally four times daily. High-risk community care: thiamine 200–300 mg intramuscularly once daily for at least 3 days with daily review. High-risk hospital care: 200–300 mg intramuscularly or intravenously once daily for 3–5 days; follow every parenteral course with oral thiamine.

Oral absorption may be negligible in malnutrition or dependence, so do not use oral therapy alone for high risk or suspected disease. Give injections through trained services; use hospital intravenous treatment when IM tissue, bleeding risk or clinical status makes community injection unsuitable.

High circulating concentrations enable central nervous system delivery when rapid reversal of thiamine-deficient cerebral dysfunction is needed.

Thiamine for suspected Wernicke encephalopathy

Give thiamine 300–500 mg intravenously three times daily for 3–5 days with daily review. If symptoms remain after 5 days, give 300–500 mg intravenously once daily for a further 3–5 days and then for as long as clinical improvement continues; follow with oral thiamine.

Administer where anaphylaxis can be treated, but do not let the very small reaction risk delay an emergency regimen. Check and correct magnesium, assess refeeding risk, and seek another cause when symptoms persist.

Complications

01

Persistent amnestic syndrome

Untreated injury can leave severe anterograde memory impairment, confabulation and executive difficulty that requires structured long-term care and support.

02

Gait disability

Cerebellar and peripheral nerve injury may produce lasting imbalance, recurrent falls and loss of independent mobility and daily function.

03

Coma and death

Severe metabolic brain failure can progress to hypothermia, hypotension, reduced consciousness, cardiorespiratory instability and ultimately fatal physiological deterioration.

04

Refeeding complications

Rapid nutrition after prolonged depletion may precipitate phosphate, potassium and magnesium shifts, arrhythmia, fluid overload and respiratory failure.

Monitoring and follow-up

  • Document attention, orientation, eye movements, nystagmus, stance, gait and memory daily during intravenous treatment.
  • Check magnesium and repeat it if response is incomplete; monitor phosphate, potassium, calcium, glucose and renal function during nutritional restoration.
  • Observe for hypersensitivity during parenteral administration in an appropriately equipped setting.
  • Review diet, weight, alcohol use, adherence and continuing risk before deciding when oral prophylaxis can stop.
  • After the acute episode, assess persistent amnesia, executive dysfunction, gait difficulty and support needs for alcohol-related brain injury.

Special situations

The triad is uncommon

Requiring confusion, ataxia and eye signs together creates dangerous underdiagnosis; risk context plus one compatible feature may be enough.

Prophylaxis has levels

Oral lower-risk prevention, parenteral high-risk prevention and high-dose intravenous treatment are separate regimens and should not be interchanged.

Magnesium enables response

Hypomagnesaemia impairs conversion to active thiamine compounds and can explain failure to improve despite apparently adequate dosing.

Glucose is not forbidden

Treat life-threatening hypoglycaemia immediately; give thiamine promptly before or alongside carbohydrate rather than withholding emergency glucose.

Brands have changed

Legacy Pabrinex pair terminology is unreliable after product changes; prescribe the intended thiamine dose and route using current available preparations.

Common pitfalls

  1. 01

    Waiting for the full classical triad before giving parenteral treatment.

  2. 02

    Using oral thiamine alone in a malnourished high-risk patient or suspected Wernicke encephalopathy.

  3. 03

    Continuing only a prophylactic once-daily dose after neurological signs appear.

  4. 04

    Forgetting magnesium assessment when confusion or eye and gait signs fail to improve.

  5. 05

    Starting unrestricted nutrition in severe malnutrition without refeeding assessment and electrolyte monitoring.

  6. 06

    Copying obsolete brand-based ampoule regimens instead of prescribing a current explicit thiamine dose.